Literature DB >> 16476667

Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine.

Stephanie L Borgland1, Sharif A Taha, Federica Sarti, Howard L Fields, Antonello Bonci.   

Abstract

Dopamine neurons in the ventral tegmental area (VTA) represent a critical site of synaptic plasticity induced by addictive drugs. Orexin/hypocretin-containing neurons in the lateral hypothalamus project to the VTA, and behavioral studies have suggested that orexin neurons play an important role in motivation, feeding, and adaptive behaviors. However, the role of orexin signaling in neural plasticity is poorly understood. The present study shows that in vitro application of orexin A induces potentiation of N-methyl-D-aspartate receptor (NMDAR)-mediated neurotransmission via a PLC/PKC-dependent insertion of NMDARs in VTA dopamine neuron synapses. Furthermore, in vivo administration of an orexin 1 receptor antagonist blocks locomotor sensitization to cocaine and occludes cocaine-induced potentiation of excitatory currents in VTA dopamine neurons. These results provide in vitro and in vivo evidence for a critical role of orexin signaling in the VTA in neural plasticity relevant to addiction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476667     DOI: 10.1016/j.neuron.2006.01.016

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  288 in total

1.  Requirement of phospholipase C and protein kinase C in cholecystokinin-mediated facilitation of NMDA channel function and anxiety-like behavior.

Authors:  Zhaoyang Xiao; Manoj K Jaiswal; Pan-Yue Deng; Toshimitsu Matsui; Hee-Sup Shin; James E Porter; Saobo Lei
Journal:  Hippocampus       Date:  2011-11-10       Impact factor: 3.899

2.  Methamphetamine-evoked depression of GABA(B) receptor signaling in GABA neurons of the VTA.

Authors:  Claire L Padgett; Arnaud L Lalive; Kelly R Tan; Miho Terunuma; Michaelanne B Munoz; Menelas N Pangalos; José Martínez-Hernández; Masahiko Watanabe; Stephen J Moss; Rafael Luján; Christian Lüscher; Paul A Slesinger
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

3.  Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice.

Authors:  Thorfinn T Riday; Eric W Fish; J Elliott Robinson; Thomas M Jarrett; Megan M McGuigan; C J Malanga
Journal:  Brain Res       Date:  2011-11-07       Impact factor: 3.252

Review 4.  Hypocretins in the control of sleep and wakefulness.

Authors:  Patricia Bonnavion; Luis de Lecea
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 5.  Hypocretin/orexin involvement in reward and reinforcement.

Authors:  Rodrigo A España
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

6.  Cocaine potentiates excitatory drive in the perifornical/lateral hypothalamus.

Authors:  Jiann Wei Yeoh; Morgan H James; Phillip Jobling; Jaideep S Bains; Brett A Graham; Christopher V Dayas
Journal:  J Physiol       Date:  2012-05-28       Impact factor: 5.182

7.  Loss of neurotensin receptor-1 disrupts the control of the mesolimbic dopamine system by leptin and promotes hedonic feeding and obesity.

Authors:  Darren Opland; Amy Sutton; Hillary Woodworth; Juliette Brown; Raluca Bugescu; Adriana Garcia; Lyndsay Christensen; Christopher Rhodes; Martin Myers; Gina Leinninger
Journal:  Mol Metab       Date:  2013-08-07       Impact factor: 7.422

8.  Activation of afferents to the ventral tegmental area in response to acute amphetamine: a double-labelling study.

Authors:  Joyce Colussi-Mas; Stefanie Geisler; Luc Zimmer; Daniel S Zahm; Anne Bérod
Journal:  Eur J Neurosci       Date:  2007-08       Impact factor: 3.386

9.  Activation of orexin/hypocretin projections to basal forebrain and paraventricular thalamus by acute nicotine.

Authors:  Ravi K Pasumarthi; Jim Fadel
Journal:  Brain Res Bull       Date:  2008-10-23       Impact factor: 4.077

10.  The anorexic agents, sibutramine and fenfluramine, depress GABA(B)-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells.

Authors:  Ada Ledonne; Luca Sebastianelli; Mauro Federici; Giorgio Bernardi; Nicola Biagio Mercuri
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.